FindMyRecallSubscribe
Class I: serious health riskTerminated

MasterPharm Finasteride Plus 1 Recall

Finasteride Plus 1

MasterPharm LLC · South Richmond Hill, NY

Risk level
Class I
Reported by FDA
May 20, 2020
Recall ID
D-1269-2020
Check your lot numberHow we source this data

Summary

MasterPharm recalled Finasteride Plus 1 starting Apr 14, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1269-2020 on May 20, 2020. Reason: Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil. Status: Terminated.

Why it was recalled

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Product description

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Lot numbers, UPCs & expiration codes

Lot #02-27-2020:04@11, Exp. August 25, 2020.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1269-2020
Classification
Class I
Status
Terminated
Recall initiated
Apr 14, 2020
FDA report date
May 20, 2020
Quantity
7260 capsules
Recall type
Voluntary: Firm initiated
Recalling firm
MasterPharm LLC

Original FDA data

Every field from FDA enforcement report D-1269-2020, exactly as published.

Show all FDA fields
City
South Richmond Hill
State
NY
Status
Terminated
Country
United States
Event ID
85619
Address
11502 Liberty Ave Fl 2
Code information
Lot #02-27-2020:04@11, Exp. August 25, 2020.
Postal code
11419-1902
Report date
May 20, 2020
Product type
Drugs
Recall number
D-1269-2020
Classification
Class I
Recalling firm
MasterPharm LLC
Product quantity
7260 capsules
Termination date
Sep 7, 2023
Reason for recall
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Apr 14, 2020
Initial firm notification
Telephone
Center classification date
May 19, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1269-2020, published May 20, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls